In 37 patients with chronic renal failure (CRF) serum amylase was higher than in 33 normal subjects (483 U/L ± SD 185 versus 267 ± SD 66 U/L, p < 0.05); while the percentage of pancreatic isoenzymes was within normal limits in 34 patients and only slightly increased in 3. Seventeen of the patients were on conservative treatment, 10 on hemodialysis and 10 on continuous ambulatory peritoneal dialysis; no significant differences in serum amylase levels were detected between these subgroups. No correlation was found between serum BUN or creatinine and serum amylase but a positive correlation was found between these enzyme levels and duration of CRF (p < 0.05) in the patients on conservative treatment.
BlaineyJ.D., NorthamB.E.Amylase excretion by human kidney. Clin Sci, 1967; 32, 377–83.
2.
DuaneW.C., FrerichsR., LevittM.D.Distribution, turnover and mechanism of renal excretion of amylase in the baboon. J Clin Invest, 1971; 50, 156–65.
3.
NodaA.Renal handling of amylase: evidence for reabsorption by stop-flow analysis. Metabolism, 1972; 21, 351–5.
4.
FredrikssonA., JacobsonG.Influence of renal function on the urinary excretion of amylase. Scand J Clin Lab Invest, 1974; 33, 313–21.
5.
DuaneW.C., FrerichsR., LevittM.D.Simultaneous study of the metabolic turnover and renal excretion of salivary amylase-125 I and pancreatic amylase-131 I in the baboon. J Clin Invest, 1972; 51, 1504–12.
6.
MortonW.J., TedescoF.J., HerschelR.H., AlpersD.H.Serum amylase determinations and amylase to creatinine clearance ratios in patients with chronic renal insufficiency. Gastroenterology, 1976; 71, 594–8.
7.
KeoghJ.B., Mc GeeneyK.F., DruryM.I., CounihanT.B., O'DonnelM.D.Renal clearance of pancreatic and salivary amylase relative to creatinine in patients with chronic renal insufficiency. Gut, 1978; 19, 1125–30.
8.
BerkJ.E., FridhandlerL., NessR.L.N.Amylase and isoamylase activities in renal insufficiency. Ann Int Med1979; 90, 351–3.
FahrenkrugJ., Staun-OlsenP., MagidE.Immunoreactive trypsin and pancreatic isoamylase activity in serum of patients with chronic renal failure or hepatic cirrhosis. Clin Chem1981; 27, 1655–7.
11.
MeroneyW.I., LawsonN.L., RubiniM.E., CarboneJ.V.Some observations of the behavior of amylase in relation to acute renal insufficiency. N E J Med, 1956; 225, 315–20.
12.
SchleinE.M., SpoonerG.R., CadeJ.R.Serum-enzymes in dialysis patients. Lancet1970ii; 422.
13.
PasternakA.Serum-amylase in dialysis patients. Lancet1971i; 343.
O'DonnellM.D., Mc GeeneyK.F.Purification and property of an alpha-amylase inhibitor from wheat. Bioch Biophys Acta, 1976; 422, 159–69.
16.
SaltW.B., SchenkerS.Amylase - Its clinical significance; a review of literature. Medicine, 1976; 55, 269–87.
17.
O'DonnellM.D., FitzgeraldO., Mc GeeneyK.F.Differential serum amylase determination by use of an inhibitor and design of a routine procedure. Clin Chem1977; 23, 560–6.
18.
BerkJ.E., FridhandlerL.Hyperamylasemia: interpretation and newer approaches to evaluation. Ann Int Med1980; 26, 235–88.
19.
HeifetzC., ProbsteinJ., GrayS.Clinical studies on blood diastase. II. Significance of increased blood diastase. Arch Intern Med, 1941; 67, 819–27.
20.
MalinowskyT.S.Clinical value of serum amylase determination. JAMA, 1952; 149, 1380–5.
